The use of high-speed differential scanning calorimetry (Hyper-DSC™) in the study of pharmaceutical polymorphs

International Journal of Pharmaceutics

Volumn 350, Issue 1-2, 2008, Pages 48-52

  McGregor, Caroline ^a   Bines, Emma ^b  

^a Merck Sharp & Dohme Limited   (United Kingdom)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

High speed DSC; Hyper DSC ; Polymorphism

Indexed keywords

CARBAMAZEPINE;

ARTICLE; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG CONFORMATION; DRUG INDUSTRY; DRUG PURIFICATION; DRUG RESEARCH; ENTHALPY; KINETICS; MELTING POINT; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; TEMPERATURE SENSITIVITY; THERMAL ANALYSIS;

CALORIMETRY, DIFFERENTIAL SCANNING; CARBAMAZEPINE; CRYSTALLIZATION; DRUG CONTAMINATION; HEAT; PHARMACEUTICAL PREPARATIONS; THERMODYNAMICS;

EID: 38349160391     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.08.015     Document Type: Article

References (17)

1. Agatonovic-Kustrin S., Tucker I.G., and Schmierer D. Solid-state assay of Ranitidine HCl as a bulk drug and as active ingredient in tablets using DRIFT spectroscopy with artificial neural networks. Pharm. Res. 16 (1999) 1477-1482
2. Brittain H.G. Methods for the characterisation of polymorphs and solvates. In: Brittain H.G. (Ed). Polymorphism in Pharmaceutical Solids (1999), Marcel Dekker, New York 227-278
3. Bugay D.E. Solid state nuclear magnetic resonance spectroscopy: theory and pharmaceutical applications. Pharm. Res. 10 (1993) 317-327
4. Burger A., and Lettenbichler A. Polymorphism and preformulation studies of lifibrol. Eur. J. Pharm. Biol. 49 (2000) 65-72
5. Cooper V.B., Pearce G.E.S., and Petts C.R. Quantification of crystalline forms in active pharmaceutical ingredient and tablets by X-ray powder diffraction. J. Pharm. Pharmacol. 55 (2003) 1323-1329
6. Findlay W.P., and Bugay D.E. Utilization of Fourier transform Raman spectroscopy for the study of pharmaceutical crystal forms. J. Pharm. Biomed. Anal. 16 (1998) 921-930
7. Garcia E., Veesler S., Boistelle B., and Hoff C. Crystallization and dissolution of pharmaceutical compounds: an experimental approach. J. Cryst. Growth 198/199 (1999) 1360-1364
8. Giron D. Impact of solid state reactions on medicaments. Mol. Cryst. Liq. Cryst. 161 (1988) 77-100
9. Giron D. Thermal analysis and calorimetric methods in the characterisation of polymorphs and solvates. Thermochim. Acta 248 (1995) 1-59
10. Gramaglia D., Conway B.R., Kett V.L., Malcolm R.K., and Batchelor H.K. High speed DSC (hyper-DSC) as a tool to measure the solubility of a drug within a solid or semi-solid matrix. Int. J. Pharm. 301 (2005) 1-5
11. Leonidov N. Polymorphism and qualitative differences in drug effects. Eur. J. Pharm. Sci. 4 (1996) S95
12. McGregor C., Saunders M.H., Buckton G., and Saklatvala R.D. The use of high-speed differential scanning calorimetry (Hyper-DSC™) to study the thermal properties of Carbamazepine polymorphs. Thermochim. Acta 417 (2004) 231-237
13. Patel A.D., Luner P.E., and Kemper M.S. Quantitative analysis of polymorphs in binary and multi-component powder mixtures by near-infrared reflectance spectroscopy. Int. J. Pharm. 206 (2000) 63-74
14. Saunders M.H., Podluii K., Shergill S., Buckton G., and Royall P.G. The potential of high speed DSC (Hyper-DSC) for the detection and quantification of small amounts of amorphous content in predominantly crystalline samples. Int. J. Pharm. 274 (2004) 35-40
15. Suryanarayanan R., and Herman C.S. Quantitative analysis of the active ingredient in a multi-component tablet formulation by powder X-ray diffractometry. Int. J. Pharm. 77 (1991) 287-295
16. Verdonck E., Schaap K., and Thomas L.C. A discussion of the principles and applications of modulated temperature DSC (MTDSC). Int. J. Pharm. 192 (1999) 3-20
17. Walking W.D., Sisco W.R., Newton M.P., Fegely B.J., Plampin J.N., and Chrzanowski F.A. Stability of Fenretinide polymorphs. Acta Pharm. Technol. 32 (1986) 10-12